Published in Eukaryot Cell on March 19, 2010
Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics (2011) 2.53
Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun (2011) 1.77
Mitosis in the human malaria parasite Plasmodium falciparum. Eukaryot Cell (2011) 1.09
An essential Aurora-related kinase transiently associates with spindle pole bodies during Plasmodium falciparum erythrocytic schizogony. Mol Microbiol (2010) 1.06
Quantitative trait loci mapping reveals candidate pathways regulating cell cycle duration in Plasmodium falciparum. BMC Genomics (2010) 1.02
Toxoplasma and Plasmodium protein kinases: roles in invasion and host cell remodelling. Int J Parasitol (2011) 0.91
The Cryptosporidium parvum kinome. BMC Genomics (2011) 0.86
Plasmodium falciparum NIMA-related kinase Pfnek-1: sex specificity and assessment of essentiality for the erythrocytic asexual cycle. Microbiology (2011) 0.86
Arrest of nuclear division in Plasmodium through blockage of erythrocyte surface exposed ribosomal protein P2. PLoS Pathog (2012) 0.86
An evolutionary perspective on the kinome of malaria parasites. Philos Trans R Soc Lond B Biol Sci (2012) 0.85
Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene. Antimicrob Agents Chemother (2012) 0.78
Regulation of DNA replication proteins in parasitic protozoans: possible role of CDK-like kinases. Curr Genet (2016) 0.76
Correlation between Cyclin Dependent Kinases and Artemisinin-Induced Dormancy in Plasmodium falciparum In Vitro. PLoS One (2016) 0.75
Chemical interrogation of the malaria kinome. Chembiochem (2014) 0.75
Checkpoints of apicomplexan cell division identified in Toxoplasma gondii. PLoS Pathog (2017) 0.75
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
Pfam: clans, web tools and services. Nucleic Acids Res (2006) 34.83
Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science (1991) 13.85
Discovery of gene function by expression profiling of the malaria parasite life cycle. Science (2003) 10.57
Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol (1997) 9.87
Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol (1991) 9.39
A decade of CDK5. Nat Rev Mol Cell Biol (2001) 5.24
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol (2005) 4.92
Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics (2004) 3.68
Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol Biochem Parasitol (2004) 3.13
Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci U S A (2008) 3.10
TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature (2000) 2.76
Comparative genomics of transcriptional control in the human malaria parasite Plasmodium falciparum. Genome Res (2004) 2.66
BUR kinase selectively regulates H3 K4 trimethylation and H2B ubiquitylation through recruitment of the PAF elongation complex. Curr Biol (2005) 2.32
Bur1 kinase is required for efficient transcription elongation by RNA polymerase II. Mol Cell Biol (2003) 2.08
SGV1 encodes a CDC28/cdc2-related kinase required for a G alpha subunit-mediated adaptive response to pheromone in S. cerevisiae. Cell (1991) 1.74
Regulation of histone modification and cryptic transcription by the Bur1 and Paf1 complexes. EMBO J (2007) 1.73
Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene (2004) 1.73
Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum. PLoS Biol (2009) 1.72
Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition. Structure (2003) 1.68
A genomic perspective of protein kinases in Plasmodium falciparum. Proteins (2005) 1.67
Phosphorylation of the RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase. Mol Cell Biol (2001) 1.61
Malaria and the cell cycle. Parasitol Today (1996) 1.56
Prediction of the general transcription factors associated with RNA polymerase II in Plasmodium falciparum: conserved features and differences relative to other eukaryotes. BMC Genomics (2005) 1.53
Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics. Mol Microbiol (2007) 1.44
The cdk-activating kinase (CAK): from yeast to mammals. Cell Mol Life Sci (1999) 1.42
Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J Med Chem (2009) 1.42
Design and synthesis of Pfmrk inhibitors as potential antimalarial agents. Bioorg Med Chem Lett (2001) 1.38
Drug resistance hampers our capacity to roll back malaria. Clin Infect Dis (2005) 1.35
Role of CDK/cyclin complexes in transcription and RNA splicing. Cell Signal (2005) 1.32
BUR1 and BUR2 encode a divergent cyclin-dependent kinase-cyclin complex important for transcription in vivo. Mol Cell Biol (2000) 1.28
ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem (2002) 1.21
Activation of the Bur1-Bur2 cyclin-dependent kinase complex by Cak1. Mol Cell Biol (2002) 1.17
Mechanisms of gene regulation in Plasmodium. Am J Trop Med Hyg (2007) 1.15
Antimalarial drug discovery: targeting protein kinases. Expert Opin Ther Targets (2007) 1.11
Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene (2001) 1.07
CDK activation by non-cyclin proteins. Curr Opin Cell Biol (2006) 1.07
PfPK6, a novel cyclin-dependent kinase/mitogen-activated protein kinase-related protein kinase from Plasmodium falciparum. Biochem J (2000) 1.06
Pfcrk-1, a developmentally regulated cdc2-related protein kinase of Plasmodium falciparum. Mol Biochem Parasitol (1995) 1.05
PlasmoDB v5: new looks, new genomes. Trends Parasitol (2006) 1.03
Identification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparum. J Biol Chem (2003) 1.01
Activation of a Plasmodium falciparum cdc2-related kinase by heterologous p25 and cyclin H. Functional characterization of a P. falciparum cyclin homologue. J Biol Chem (2000) 0.99
Characterisation of the rhoph2 gene of Plasmodium falciparum and Plasmodium yoelii. Mol Biochem Parasitol (2003) 0.97
Sequence patterns in protein kinases. Nature (1988) 0.97
Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth. FEMS Microbiol Lett (2008) 0.95
Isolation and expression of a gene specifying a cdc2-like protein kinase from the human malaria parasite Plasmodium falciparum. Eur J Biochem (1994) 0.90
Pfmrk, a MO15-related protein kinase from Plasmodium falciparum. Gene cloning, sequence, stage-specific expression and chromosome localization. Eur J Biochem (1996) 0.89
Studies on cell-cycle synchronization in the asexual erythrocytic stages of Plasmodium falciparum. Parasitology (2006) 0.89
Differential sub-nuclear localisation of repressive and activating histone methyl modifications in P. falciparum. Microbes Infect (2008) 0.88
Pbcrk-1, the Plasmodium berghei orthologue of P. falciparum cdc-2 related kinase-1 (Pfcrk-1), is essential for completion of the intraerythrocytic asexual cycle. Exp Parasitol (2005) 0.86
Some recent advances in the cultivation of Plasmodium falciparum. Isr J Med Sci (1978) 0.84
Raising antibodies in chickens against primaquine, pyrimethamine, dapsone, tetracycline, and doxycycline. Immunol Invest (2005) 0.81
Influence of human p16(INK4) and p21(CIP1) on the in vitro activity of recombinant Plasmodium falciparum cyclin-dependent protein kinases. Biochem Biophys Res Commun (2001) 0.79
Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics (2004) 3.68
A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog (2006) 2.92
Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"? Health Serv Res (2006) 2.14
The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands. J Exp Med (2010) 2.08
It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park) (2013) 2.07
The flaws in state 'apology' and 'disclosure' laws dilute their intended impact on malpractice suits. Health Aff (Millwood) (2010) 1.95
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. J Med Chem (2005) 1.81
Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun (2011) 1.77
Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition. Structure (2003) 1.68
Marine actinomycetes: a new source of compounds against the human malaria parasite. PLoS One (2008) 1.67
Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials. J Med Chem (2007) 1.60
A novel protein kinase family in Plasmodium falciparum is differentially transcribed and secreted to various cellular compartments of the host cell. Mol Microbiol (2007) 1.48
Randomized control of extracorporeal shock wave therapy versus placebo for chronic decubitus ulceration. Clin Rehabil (2010) 1.46
A NIMA-related protein kinase is essential for completion of the sexual cycle of malaria parasites. J Biol Chem (2005) 1.44
Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics. Mol Microbiol (2007) 1.44
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase. Antimicrob Agents Chemother (2007) 1.43
Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med (2004) 1.36
The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation. Prog Cell Cycle Res (2003) 1.33
An atypical mitogen-activated protein kinase controls cytokinesis and flagellar motility during male gamete formation in a malaria parasite. Mol Microbiol (2005) 1.33
PfeIK1, a eukaryotic initiation factor 2alpha kinase of the human malaria parasite Plasmodium falciparum, regulates stress-response to amino-acid starvation. Malar J (2009) 1.31
A stretch-activated anion channel is up-regulated by the malaria parasite Plasmodium falciparum. J Physiol (2002) 1.29
Callophycoic acids and callophycols from the Fijian red alga Callophycus serratus. J Org Chem (2007) 1.29
An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites. J Biol Chem (2009) 1.26
Disruption of the PfPK7 gene impairs schizogony and sporogony in the human malaria parasite Plasmodium falciparum. Eukaryot Cell (2007) 1.25
Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality. Mol Microbiol (2009) 1.25
Plasmodium falciparum: genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment. Exp Parasitol (2007) 1.21
Drugging the Plasmodium kinome: the benefits of academia-industry synergy. Trends Pharmacol Sci (2008) 1.19
Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratus. J Org Chem (2009) 1.19
Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum. J Biol Chem (2005) 1.18
PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum. Mol Microbiol (2005) 1.18
Bioactive bromophycolides R-U from the Fijian red alga Callophycus serratus. J Nat Prod (2010) 1.17
Mechanisms of gene regulation in Plasmodium. Am J Trop Med Hyg (2007) 1.15
Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. J Proteome Res (2013) 1.15
Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol J (2009) 1.14
The protein-phosphatome of the human malaria parasite Plasmodium falciparum. BMC Genomics (2008) 1.08
Plasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductance. PLoS Pathog (2008) 1.06
An essential Aurora-related kinase transiently associates with spindle pole bodies during Plasmodium falciparum erythrocytic schizogony. Mol Microbiol (2010) 1.06
Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors. Biochim Biophys Acta (2004) 1.06
Regulatory motifs uncovered among gene expression clusters in Plasmodium falciparum. Mol Biochem Parasitol (2007) 1.06
Plasmodium falciparum responds to amino acid starvation by entering into a hibernatory state. Proc Natl Acad Sci U S A (2012) 1.05
In vivo imaging enters parasitology. Trends Parasitol (2006) 1.05
The complement of protein kinases of the microsporidium Encephalitozoon cuniculi in relation to those of Saccharomyces cerevisiae and Schizosaccharomyces pombe. BMC Genomics (2007) 1.04
Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp. Bioorg Med Chem (2006) 1.03
A mitogen-activated protein kinase regulates male gametogenesis and transmission of the malaria parasite Plasmodium berghei. EMBO Rep (2005) 1.03
Genetic basis of murine lupus. Autoimmun Rev (2004) 1.03
Malaria: targeting parasite and host cell kinomes. Biochim Biophys Acta (2009) 1.03
Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev (2004) 1.02
Are Ayurvedic herbs for diabetes effective? J Fam Pract (2005) 1.01
Cyclin-dependent kinase homologues of Plasmodium falciparum. Int J Parasitol (2002) 1.01
Identification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparum. J Biol Chem (2003) 1.01
Alisiaquinones and alisiaquinol, dual inhibitors of Plasmodium falciparum enzyme targets from a New Caledonian deep water sponge. J Nat Prod (2008) 0.99
Malaria parasites form filamentous cell-to-cell connections during reproduction in the mosquito midgut. Cell Res (2010) 0.98
Functional analysis of protein kinase CK2 of the human malaria parasite Plasmodium falciparum. Eukaryot Cell (2008) 0.98
Identification of Plasmodium falciparum family of SNAREs. Mol Biochem Parasitol (2006) 0.98
A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum: identification of four purine transport activities in intraerythrocytic parasites. Biochem J (2008) 0.96
The kinomes of apicomplexan parasites. Microbes Infect (2012) 0.96
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites. J Med Chem (2006) 0.95
Molecular machinery of signal transduction and cell cycle regulation in Plasmodium. Mol Biochem Parasitol (2009) 0.95
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. Bioorg Med Chem (2004) 0.95
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design. Structure (2008) 0.94
Antibacterial neurymenolides from the Fijian red alga Neurymenia fraxinifolia. Org Lett (2009) 0.94
Characterization of a PRL protein tyrosine phosphatase from Plasmodium falciparum. Mol Biochem Parasitol (2007) 0.93
Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites. Angew Chem Int Ed Engl (2005) 0.92
Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor. J Cell Biochem (2011) 0.92
Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep (2004) 0.91
Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis. ACS Med Chem Lett (2013) 0.91
Plasmodium kinases as targets for new-generation antimalarials. Future Med Chem (2012) 0.91
Toxoplasma and Plasmodium protein kinases: roles in invasion and host cell remodelling. Int J Parasitol (2011) 0.91
Synthesis of 3-(1,2,3-triazol-1-yl)- and 3-(1,2,3-triazol-4-yl)-substituted pyrazolo[3,4-d]pyrimidin-4-amines via click chemistry: potential inhibitors of the Plasmodium falciparum PfPK7 protein kinase. Org Biomol Chem (2009) 0.90
Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes. Cell Microbiol (2011) 0.90
Calcium storage and function in apicomplexan parasites. Essays Biochem (2011) 0.89
The Sgp3 locus on mouse chromosome 13 regulates nephritogenic gp70 autoantigen expression and predisposes to autoimmunity. J Immunol (2003) 0.89
2-Oxo-tetrahydro-1,8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials. Bioorg Med Chem Lett (2007) 0.89
Selective increase of autoimmune epitope expression on aged erythrocytes in mice: implications in anti-erythrocyte autoimmune responses. J Autoimmun (2002) 0.88
CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Malar J (2010) 0.88
Phytochemical Assays of Commercial Botanical Dietary Supplements. Evid Based Complement Alternat Med (2004) 0.88
Bromophycolide A targets heme crystallization in the human malaria parasite Plasmodium falciparum. ChemMedChem (2011) 0.88
Expression in yeast links field polymorphisms in PfATP6 to in vitro artemisinin resistance and identifies new inhibitor classes. J Infect Dis (2013) 0.88
Characterization of a unique aspartate-rich protein of the SET/TAF-family in the human malaria parasite, Plasmodium falciparum, which inhibits protein phosphatase 2A. Mol Biochem Parasitol (2003) 0.87
Rabdosia rubescens inhibits breast cancer growth and angiogenesis. Int J Oncol (2005) 0.87
TgVTC2 is involved in polyphosphate accumulation in Toxoplasma gondii. Mol Biochem Parasitol (2010) 0.87
Pbcrk-1, the Plasmodium berghei orthologue of P. falciparum cdc-2 related kinase-1 (Pfcrk-1), is essential for completion of the intraerythrocytic asexual cycle. Exp Parasitol (2005) 0.86
An image analysis algorithm for malaria parasite stage classification and viability quantification. PLoS One (2013) 0.86
Plasmodium falciparum NIMA-related kinase Pfnek-1: sex specificity and assessment of essentiality for the erythrocytic asexual cycle. Microbiology (2011) 0.86
Evidence for prenylation-dependent targeting of a Ykt6 SNARE in Plasmodium falciparum. Mol Biochem Parasitol (2010) 0.85